Zhuowei Liu

15PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 10, 2024
Enhanced Oxidative Phosphorylation Driven by TACO1 Mitochondrial Translocation Promotes Stemness and Cisplatin Resistance in Bladder Cancer.

Minhua Deng, Zhaohui Zhou, Jiawei Chen

|May 08, 2024
Tumor-repopulating cells evade ferroptosis via PCK2-dependent phospholipid remodeling.

Zhe Li, Zhi-Min Xu, Wei-Peng Chen

|Dec 12, 2023
G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC-I via PI3K/Akt Activation in Bladder Cancer.

Xianchong Zheng, Jiawei Chen, Minhua Deng

|Nov 27, 2023
Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinoma.

Xin An, Cong Xue, Meiting Chen

|Nov 14, 2023
Optimal interval timing between transurethral resection of bladder tumors and Bacillus Calmette-Guerin perfusion.

Tao-Nong Cai, Jiang-Li Lu, Zhi Chen

|Sep 05, 2023
AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer.

Zikun Ma, Zhiyong Li, Yize Mao

Pageof 3

Frequent Collaborators

4 joint publications

Yunlin Ye

3 joint publications

Fangjian Zhou

2 joint publications

Wensu Wei

2 joint publications

Zhaohui Zhou